Skip to main content

ORIGINAL RESEARCH article

Front. Virtual Real.
Sec. Virtual Reality in Medicine
Volume 5 - 2024 | doi: 10.3389/frvir.2024.1466362

Observational cohort study of a group-based VR program to improve mental health and well-being in people with life-threatening illnesses

Provisionally accepted
  • 1 Centre for Psychedelic Research, Imperial College London, London, United Kingdom
  • 2 Psychedelics Division, Neuroscape, Department of Neurology, Physiology and Psychiatry, University of California San Francisco, San Francisco, United States
  • 3 aNUma, Inc., San Rafael, CA, United States
  • 4 Intangible Realities Laboratory, Centro Singular de Investigación en Tecnoloxías Intelixentes da USC, Universidade de Santiago de Compostela, Santiago de Compostela, Spain
  • 5 Numadelic Labs, El Cerrito, CA, United States
  • 6 Departments of Physiology and Psychiatry, University of California San Francisco, San Francisco, CA, United States
  • 7 Department of Psychology, University of Exeter, Exeter, United Kingdom

The final, formatted version of the article will be published soon.

    Introduction. Being diagnosed with a life-threatening illness (LTI) is often accompanied by feelings of fear, uncertainty, and loneliness that can severely impact mental health. Relatively few interventions are available to address the existential concerns of individuals facing LTI, while treatment of the underlying physical ailment typically remains the priority of the healthcare system. Research has shown that psychedelic-assisted psychotherapy (PAT) holds promise for supporting mental health in people with LTIs. However, PAT’s potential in this population remains curtailed by several limitations, including regulatory and accessibility issues. Novel approaches that could provide some of the benefits of psychedelic experiences, while avoiding associated challenges, would therefore be highly desirable for supporting the mental well-being of people with LTIs. Among such interventions, VR-based experiences have been suggested as a promising candidate. We here evaluate a program that includes weakly representational, multi-user VR experiences based on a design aesthetic previously described as “numadelic”, which has been demonstrated to elicit self-transcendent experiences comparable to psychedelics. Methods. A prospective cohort study design was used to assess the effects of “Clear Light” (CL) a group-based, 6-session multimedia program that included VR experiences, video calls, and text chats spanning 3 weeks. Participants were individuals suffering from LTIs that self-selected to participate in the CL program. A total of N=15 participants were evaluated based on assessments one week before and after the program, using self-report measures of anxiety, depression, well-being, and secondary psychological outcomes. Results. The intervention was well-tolerated among participants. Significant improvements with moderate effect sizes were observed on self-reported measures of anxiety, depression, and well-being. Secondary measures assessing demoralization, connectedness, and spiritual well-being also showed significant improvements. Discussion. This observational study demonstrated the feasibility and potential benefits of a group-based VR program that can be delivered at-home to people suffering from LTIs. While conclusions are presently limited by the lack of randomization or a comparison group, our findings strongly suggest further research is warranted, including randomized controlled trials.

    Keywords: virtual reality, Life-threatening illness, Well-being, Anxiety, Depression, Psychosocial intervention, Internet-based intervention, cohort study

    Received: 17 Jul 2024; Accepted: 03 Dec 2024.

    Copyright: © 2024 Kettner, Glowacki, Wall, Carhart-Harris, Roseman and Hardy. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Hannes Simon Kettner, Centre for Psychedelic Research, Imperial College London, London, United Kingdom
    Joseph Hardy, aNUma, Inc., San Rafael, CA, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.